A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Status:
Recruiting
Trial end date:
2024-10-23
Target enrollment:
Participant gender:
Summary
The reason for this study is to determine if the study drug LY3471851 is safe and effective
in adult participants with active ulcerative colitis (UC). The study will last about 52
weeks.